Average of confirmed sales; the main valuation baseline.
Lowest active listing; an asking price, not a completed sale.
Reference-price movement; low volume can make it unstable.
More sales reduce the impact of individual transactions.
Sales answer “what is it worth”; listings answer “what does an available copy cost”.
| DATE | SOURCE | Price | Change |
|---|---|---|---|
| 2026-10-14 | Sold | €1.00 | — |
| 2026-10-12 | Sold | €1.00 | — |
| 2026-10-11 | Sold | €1.00 | — |
| 2026-10-11 | List | €79.50 | -11.7% |
| 2026-10-10 | Sold | €1.00 | — |
| 2026-10-09 | Sold | €1.00 | — |
| 2026-10-08 | Sold | €1.00 | — |
| 2026-10-07 | Sold | €1.00 | — |
| 2026-10-06 | Sold | €1.00 | — |
| 2026-10-05 | Sold | €1.00 | — |
| 2026-10-04 | Sold | €1.00 | — |
| 2026-10-03 | Sold | €1.00 | — |
| 2026-10-02 | Sold | €1.00 | — |
| 2026-10-01 | Sold | €1.00 | — |
Facing a New Trial / #051
Germany: lowest · Spain: above average · EU average €84.75Choose a region above to inspect its prices and history.
DETAILED PRICES · Price History
| Condition/Grade | Price | LOW | HIGH | 7D CHG | Volume | Spark |
|---|---|---|---|---|---|---|
AggregatedRAW | €1.00 | €79.00 | €1.00 | 0.0% | >5 | |
NMRAW | €1.00 | €79.00 | €1.00 | 0.0% | >5 |
Explore Salazzle GX (sm2+ 051) Facing a New Trial JP #051, Normal from Facing a New Trial, with 326 price records for the EU market. Prices above are labeled by source, currency and condition. Asking prices and recorded sales are different measures, not interchangeable valuations.